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Abstract
Tetracycline-dependent transgenes promise to be an important tool for investigating the time dependence of gene function during mouse
development. The pivotal element of this approach is the recombinant tetracycline-dependent transactivator tTA. Using a modi®ed gene trap
approach we successfully generated mouse lines expressing tTA in a wide spread manner during embryogenesis. The transgenic model
system which we established allowed us to depict transactivator and target gene expression patterns with high resolution by histochemical
means. Our data provide evidence that with decreasing concentrations of tTA protein the state of chromatin acetylation becomes an
increasingly important determinant for tTA function. The observation of tTA-dependent position effects on tetO-linked target genes suggests
that transcription patterns can be encoded at the level of promoter preactivation. q 1999 Elsevier Science Ireland Ltd. All rights reserved.
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1. Introduction
Inducible transgenes are important analytical tools in the
developmental genetics of Drosophila and C. elegans.
However the establishment of an equivalent instrument for
the mouse is still in its infancy. One of the most promising
approaches along this line is the tetracycline-dependent acti-
vator system (Gossen and Bujard, 1992). The pivotal
element of this approach is the recombinant tTA gene
which encodes a transcriptional activator (Gossen and
Bujard, 1992), here called TetR-VP16. Its DNA binding
function is conferred by the procaryotic Tet repressor
protein (TetR) which has been fused to the VP16 activation
domain.
TetR binds as a homodimer with a large free energy
change (KA < 2 £ 1011 M21) to its palindromic operator
sequences (Hillen et al., 1983; Kleinschmidt et al., 1988).
The formation of the operator-TetR complex is ef®ciently
inhibited by binding of tetracycline which is effective at
very low, non-toxic concentrations due to its high af®nity
for TetR (MuÈller et al., 1995). Therefore, TetR-VP16 can
activate a CMV core promoter coupled to seven TetR opera-
tor sites (tetO promoter) in a tetracycline dependent manner
(Gossen and Bujard, 1992).
Initial attempts to establish the tetracycline-dependent
activator system in the mouse have been principally
encouraging ( Furth et al., 1994). The system has already
been used with success to address different physiological
questions (Efrat et al., 1995; Ewald et al., 1996; Mayford
et al., 1996). However, several problems have become
apparent, which have hindered the usage of the system for
developmental analysis. Up to now no mouse line is avail-
able which expresses tTA in early development. A high
degree of variability in activator-dependent target gene
expression has been observed using the CMV promoter
and its enhancer to express tTA ( Furth et al., 1994). Histo-
chemical analysis of target gene expression, surprisingly
revealed, that among the cells of the same tissue type only
a subset of interspersed cells showed activator dependent
target gene expression ( Furth et al., 1994). Since expression
of the activator was not analyzed concomitantly it remained
obscure if the observed mosaicism is due to, a likewise,
mosaic expression of the activator or due to particularities
of the activation mechanism. Mosaic expression has also
been observed using the CaMKIIa promoter to express
tTA in postnatal brain (Mayford et al., 1996). In addition
it was noticed that expression of tetO-linked transgenes
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appeared to be restricted to subregions of the tTA expres-
sion domain depending on the target gene's integration site
(Mayford et al., 1996).
Using transgenic promoters we were not able to obtain
early commencing, stable and widespread expression of tTA
transgenes during mouse development. Since this problem
was attributed to the usage of transgenic promoter elements
we pursued a modi®ed gene trap approach (Friedrich and
Soriano, 1991) to express tTA under the control of endo-
genous, ubiquitously active promoters. Thus, we were
successful in establishing mouse lines which ful®ll the
above criteria. This allowed for the ®rst time to study the
relationship between tTA and target gene expression during
mouse embryogenesis. The analysis suggests that below a
critical concentration TetR-VP16 relies on endogenous cis-
acting elements for promoter activation. These putative
elements determine the pattern of TetR-VP16 action with-
out activating the transgene promoter on their own. They are
therefore appropriately described as promoter preactivating
elements. Our data provide evidence that histone hyperace-
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Fig. 1. Line M34 carries vector pM26.22 (A), line B35 vector pM41.1 (B) integrated into an endogenous gene locus. (C) Target gene vector pM42.7. (D)
Experimental design. En-in, intron from mouse En2 gene; En-ex, part of En2 exon; b-geo, fusion of LacZ with neomycin phosphotransferase gene of Tn5;
IRES, internal ribosomal entry site of encephalomyocarditis virus; tTA, tetracyclin-dependent transactivator gene; rbgl-in, rabbit b-globin intron 2, pA,
polyadenylation signal of rabbit b-globin gene (A) and of SV40 (C), respectively; SV40-in, intron of SV40 (gives rise to two alternative transcripts); tetO, tetO
promoter; X-ex, exons of an endogenous gene X. SA, splice acceptor; SD, splice donor; O, tet operator site; GTF, general transcription machinery, TATA,
CMV core promoter, hAP, human placental alkaline phosphatase; tet, tetracycline; X, XbaI; B, BamHI; H, HindIII. Right angle arrows represent promoters.
tylation provides a mechanism for promoter preactivation.
Hence, activator concentration and the acetylation state of
chromatin appear to be major determinants of TetR-VP16
function in transgenic embryos. This presumably accounts
for many `undesirable' properties of the tetracycline-depen-
dent activator system in transgenic mice. The results suggest
to search for constitutively hyperacetylated integration sites




We used a modi®ed gene trap approach to set tTA under
the control of endogenous promoters which show little
temporal and spatial restriction of their activity (Fig. 1D).
Different tTA-vectors were designed to trap endogenous
promoters (Fig. 1A,B). These vectors carry downstream
of the LacZ-neomycin-phosphotransferase fusion gene
(b -geo) the tTA open reading frame fused to the internal
ribosomal entry site (IRES) of the encephalomyocarditis
(EMC) virus. The IRES element initiates translation by a
mechanism different from the ribosomal scanning mechan-
ism (Jackson et al., 1990; Kaminski et al., 1990). In frame
integration of the tTA-vector into an active locus, there-
fore, gives rise to a trifunctional, dicistronic transcript
(Fig. 1D). The distribution of the TetR-VP16 encoding
transcript can be easily depicted with high resolution by
staining for b -galactosidase activity. In order to reach the
same resolution in the analysis of target gene expression,
the tetO promoter was coupled to the cDNA of the human
placental alkaline phosphatase (Fig. 1C). This permits the
investigation of target gene expression by histochemical
means.
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Fig. 2. (A±B) Embryos stained for b-galactosidase activity. (A) M34 embryo at E12.5. (B) M34 embryo at E15.5 cut sagitally. (C) Northern transfer of total
RNA from E12.5 embryos (M34 and wildtype) hybridized with a tTA DNA probe. (D) Immuno transfer of protein from E12.5 embryos (M34 and wildtype) or
using an anti-TetR antiserum. WT, wildtype; P, positive control. This was generated by transfecting mouse ®broblasts (Lt2) with activator plasmid pUHG15-1.
2.2. Establishment of the transgenic model system
In order to trap endogenous promoters, embryonic stem
(ES) cells were electroporated with tTA gene trap vectors.
ES cells were selected for neomycin resistance and b-galac-
tosidase expression and were ®nally aggregated with mouse
morulae. From 11 aggregated ES cell clones two gave rise to
chimeras transmitting the mutation to the next generation
allowing establishment of lines M34 and B35. Embryos of
both lines exhibit a widespread LacZ expression which is
fully developed not later than E 12.5 (Figs. 2A,B and 3A,B).
Northern transfer and immunoblotting directly demon-
strated expression of the activator in mouse lines M34 and
B35 (Figs. 2C,D and 3C,D). We will refer to the promoter
trap generated activator genes as M34::tTA and B35::tTA,
respectively.
Transgenic animals carrying the target gene were gener-
ated by microinjection of zygotic pronuclei. Mouse lines
that have thus been generated are called TOPj, where j is
a natural number referring to the individual line. The respec-
tive genes will be designated as tetO::hAP-j.
2.3. Target genes are refractory to transactivation in the
majority of integration sites
Fourteen TOP lines were crossed with activator lines
M34 and B35, respectively. Embryos were genotyped and
stained for hAP activity between E12.5 and E15.5. Only one
target gene integration site represented by line TOP47
allowed for tTA-dependent expression (Figs. 4 and 5).
This shows that TetR-VP16 is expressed in a functional
manner in transgenic embryos but also indicates that most
of the target loci are refractory with respect to activation by
TetR-VP16.
2.4. Reliance on promoter preactivating position effects
Line TOP47 represents an enhancer trap event (Wilson
et al., 1990). Embryos depict a speci®c expression pattern
of the target gene even in the absence of the activator.
The endogenous enhancer function drives hAP expression
in cartilage anlagen of the limbs, vertebrae, ribs and in an
intricate craniofacial pattern including patches in the
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Fig. 3. Characterization of line B35. (A±D) like Fig. 2, except that immuno transfer (D) was done with protein of E14.5 embryos.
head dermis (Fig. 4A). Until E 14 double transgenic
embryos carrying M34::tTA in addition to the target gene
show an expression pattern that is indistinguishable from
the pattern of littermates possessing the target gene alone
(data not shown). Between E14 and E15, however, double
transgenic and only double transgenic embryos start to
express the target gene in the epidermis in a mosaic pattern
(Figs. 4C and 5C). This expression was not observed in
embryos from crossings of any other TOP line with line
M34. It has to be concluded that the tTA-dependent epider-
mal expression in TOP47 £ M34 embryos relies on a speci-
®c regulatory quality of the target gene's integration site.
The endogenous cis-acting elements which must account for
this position effect are functionally different to enhancers
since they do not activate the transgene on their own.
However, they are required for tTA-dependent activation
and are therefore, best described as promoter preactivating
elements.
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Fig. 4. Embryos stained for hAP activity with X-phosphate at E 15.5. Embryos were cut sagittally before staining. The embryos shown are littermates and have
been stained under identical conditions. (A) TOP47 embryo. (B) TOP47 £ B35 embryo. Note the enhanced hAP-expression in the cranial dermis and the ribs.
(C) TOP47 £ M34 embryo. (D) TOP47 £ B35 £ M34 embryo.
2.5. Concentration is a critical parameter for TetR-VP16
function
We analyzed target gene expression in embryos from
crossings between line TOP47 and activator line B35.
With the exception of an enhanced cranial dermis expres-
sion B35::tTA does not stimulate target gene activity (Fig.
4B). Especially, TOP47 £ B35 embryos lack any target gene
expression in the epidermis. (Figs. 4B and 5B). This indi-
cates that transactivation of tetO::hAP-47 by M34::tTA
requires a feature that distinguishes the activator locus
M34::tTA from B35::tTA. The most likely assumption is
that the two activator loci are different with respect to
their epidermal expression levels. This is supported by the
observation that the epidermis of B35 embryos exhibits a
fainter staining for b-galactosidase activity in comparison
with M34 embryos (data not shown). To test for the effect of
activator concentration on target gene expression we
increased the activator concentration by generating triple-
transgenic TOP47 £ M34 £ B35 embryos. These embryos
show an almost uniform target gene expression in the
epidermis in contrast to the mosaic expression of TOP47 £
M34 embryos (Figs. 4D and 5D). The synergism of the
activator loci indicates that the concentration of the activa-
tor is a critical parameter for its ability to activate tetO::-
hAP-47. Tripletransgenic embryos, however, do not exhibit
new activator-dependent expression domains outside the
epidermis at E 15.5 nor is the temporal frame of this expres-
sion altered. Therefore, we wanted to know if a further
increase in activator concentration could result in activation
of prior refractory promotor states. To answer this question
we isolated primary embryonic ®broblasts (MEFs) from
TOP97 £ M34 embryos. The target gene of line TOP97
does neither exhibit tTA-dependent nor tTA-independent
activity in vivo as judged by histochemical analysis of
single and double transgenic embryos (data not shown).
TOP97 £ M34-MEFs were transiently transfected with an
expression plasmid for TetR-VP16 and alkaline phospha-
tase activities were subsequently measured in extracts of
transfected cells. The results show that increasing amounts
of transfected activator plasmid lead to increasing phospha-
tase activities until a maximum is reached at 1600 ng of
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Fig. 5. Abdominal epidermis of X-phosphate stained embryos at E 15.5. (A±D) like Fig. 4. In (B) and (C) expression in the ribs can be seen through the
epidermis.
activator plasmid (Fig. 6). With this amount of transfected
activator plasmid a ,190-fold stimulation of alkaline phos-
phatase activity can be measured compared with the back-
ground level, whereas endogenous activator concentrations
lead to a four- to ®ve-fold increase (Fig. 6). A similar result
was obtained using line TOP96 which, likewise, does not
show tTA-dependent nor tTA-independent target gene
activity in vivo (data not shown). The achieved increase
in phosphatase activity is dependent on activator binding
at the tetO-promoter since it can almost completely be
repressed by culturing transfected cells in tetracycline
containing medium (Fig. 6A, compare columns 1, 8 and
9). Immuno transfer experiments show that increasing
amounts of transfected activator plasmid used in our experi-
ments, lead to increasing activator concentrations as
expected (Fig. 6B). Although the transfection procedure
itself potentiates activator function (Fig. 6, compare
columns 2, 3 and 9) the dramatic increase in target gene
activity observed in transfected cells compared with mock
transfected cells can be mainly attributed to increased intra-
cellular activator concentrations.
In summary we conclude that the concentration of TetR-
VP16 is a critical parameter for its function irrespective of
the large free energy change associated with TetR binding to
DNA. The effect of activator concentration on the mosai-
cism of target gene expression suggests that variegating
expression in the epidermis of TOP47 £ M34 embryos is
a phenomenon re¯ecting inef®cient promoter activation.
2.6. Inhibition of histone deacetylases potentiates TetR-
VP16 activity
Biochemical studies have shown that at least some tran-
scription factors can bind to hyperacetylated nucleosome
cores with af®nity constants approaching the binding af®-
nities for naked DNA (Lee et al., 1993; Vettese-Dadey et al.,
1996). In order to test if the degree of histone acetylation
in¯uences the activity of TetR-VP16, TOP96xM34-MEFs
were cultured in the presence and absence of tetracycline, at
different concentrations of sodium butyrate. Butyrate inhi-
bits histone deacetylases and thus causes global histone
hyperacetylation (Candido et al., 1978; Sealy and Chalkley,
1978). Incubation of cells with butyrate leads to alkaline
phosphatase activities exceeding background levels by
more than a 550 fold at a concentration of 10 mM in the
absence of tetracycline, whereas in the presence of tetracy-
cline the activity did not increase by more than a factor of
four (Fig. 7A). Similar results were obtained when TOP96 £
M34- and TOP97 £ M34-MEFs were treated with (R)-
trichostatin A (TSA; Fig. 7B,C). TSA is an inhibitor of
histone deacetylases which is believed to be much more
speci®c than butyrate, since it is effective at concentrations
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Fig. 6. (A) Transfection of TOP97 £ M34-MEFs. Cells have been trans-
fected with no DNA (columns 1 and 2) or a total of 5 mg of plasmid DNA
(columns 3±9) containing different amounts of activator plasmid pUHG15-
1 and control plasmid. AP, alkaline phosphatase. AP activity was normal-
ized to the average CAT activity (see Section 4) measured in cells trans-
fected with control plasmid only (column 3). AP activities are given on a
relative scale. The value measured for mock transfected cells in the
presence of tetracycline (column 1) was set to 1. Columns represent the
average of two independent experiments done in parallel. (B) Immunoblot
of protein from embryos and transfected MEFs. Equal amounts of protein of
transfected TOP96-MEFs (proteins from two independent experiments
done in parallel were pooled), and of a M34 and a wildtype embryo
(E12.5) were loaded for comparison. The amounts of transfected plasmid
are indicated below the photo. Note that , 1% of transfected cells contri-
bute to the TetR-VP16 representing band, whereas presumably 100% of the
embryo cells contribute to the TetR-VP16 representing band. P, see Fig. 2;
pUHG15-1, activator plasmid; pBS, pBluescript (Stratagene).
®ve±six orders of magnitude lower than butyrate (Yoshida
et al., 1995).
The induction of target gene activity by histone deacety-
lase inhibitors must be either due to the hyperacetylation of
chromatin at the target promoter or due to a dramatic
increase in TetR-VP16 concentration. To distinguish
between these alternatives we compared transcript levels
in TOP97 £ M34 cells treated with different amounts of
TSA. The results demonstrate that TSA does not in¯uence
the concentration of activator mRNA (Fig. 7D). However, it
does lead to different transcript concentrations of the target
gene (Fig. 7D), consistent with the induced changes in alka-
line phosphatase activity (Fig. 7C). It is therefore most
likely that the potentiation of activator activity by histone
deacetylase inhibitors is due to the hyperacetylation of chro-
matin at the target promoter.
3. Discussion
To study the activation of tetO-linked transgenes in
mouse embryos we used a modi®ed gene trap approach to
generate transgenic mice which ubiquitously express the
tetracycline-dependent transactivator gene tTA during
embryogenesis. Expression of the transgene is demonstrated
by several means. Northern transfer analysis reveals a stable
tTA-coding transcript for both activator lines investigated.
Linkage of an IRES-tTA fusion with the b -Geo gene gives
rise to a dicistronic mRNA, whose distribution can be moni-
tored by histochemical analysis. This analysis suggests
ubiquitous transcription of M34::tTA and B35::tTA, respec-
tively. Immunotransfer analysis indicates successful trans-
lation of tTA sequences into TetR-VP16. Gene trap events
isolated in our laboratory show ubiquitous expression of b -
galactosidase from IRES-LacZ fusions (data not shown).
This demonstrates that the IRES function used to direct
the translation of tTA is not subjected to any obvious restric-
tions during mouse development. We therefore, conclude
that the distribution of tTA-coding mRNA faithfully re¯ects
the expression pattern of TetR-VP16.
TetR-VP16 is expressed in a functional form. This
conclusion is based on the following observations: ®rst,
comparative histochemical analysis of TOP47 and
TOP47 £ M34 or TOP47 £ M34 £ B35 embryos reveals
tTA-dependent epidermal expression of the target gene.
Second, primary ®broblasts isolated from double transgenic
embryos and analyzed by biochemical means show tetracy-
cline-dependent target gene activity. Even in the absence of
histone deacetylase inhibitors target gene activity is clearly
dependent on tetracycline (Fig. 7A,B,C), though the stimu-
latory effect of the activator (four±®ve fold) is compara-
tively low and therefore most likely not detected by
histochemical means in vivo.
3.1. Determinants for TetR-VP16 function
Our histochemical investigations surprisingly indicated
that the tetO target gene is refractory with respect to trans-
activation by tTA loci in the majority of integration sites.
The above discussion shows that this is not due to trivial
reasons. Two possibilities can be envisaged to explain the
refractory state of target genes in the presence of the acti-
vator: either the activator ef®ciently occupies its binding
sites but transmission of the activation signal to the core
promoter is inhibited, or alternatively, binding of the acti-
vator to DNA is hampered by chromatin factors. The
observed dependence of promoter activity on the concentra-
tion of TetR-VP16 is only consistent with the second alter-
native. We therefore assume that activation of tetO-linked
target genes is repressed at the level of activator binding to
DNA. Repression of DNA binding in the context of chro-
matin has been demonstrated for several transcription
factors (Taylor et al., 1991; Kwon et al., 1994). However,
cell culture experiments have suggested that TetR-VP16
concentrations well below the detection level of immuno
transfer analysis are suf®cient for effective target gene acti-
vation (Gossen and Bujard, 1992). The difference between
these and our results is most likely due to the fact that
procedures for stable transfection always make use of coin-
tegrating selection markers. This inevitably provides a bias
for selecting accessible chromatin domains as integration
sites for the transgene (Pikaart et al., 1998).
Mosaic expression of transgenes is frequently observed
and has also been noticed implementing the tetracycline-
dependent activation system in the mouse genome ( Furth
et al., 1994; Mayford et al., 1996). We show that increasing
the activator gene dosage turns mosaic expression into
uniform target gene activity. This suggests that increasing
activator concentrations recruit an increasing number of
target templates into the active state. Our observations are
consistent with and provide the ®rst in vivo evidence for the
probabilistic model of activator function (Weintraub, 1988;
Walters et al., 1995; Felsenfeld, 1996; Zlokarnik et al.,
1998).
Since the activator depends for proper function on promo-
ter preactivating position effects it seems that M34::tTA and
B35::tTA express TetR-VP16 at a rather low level. Several
experimental observations have suggested that cells cannot
tolerate higher concentrations of TetR-VP16 (Gossen and
Bujard, 1992; Baron et al., 1997; Gallia and Khalili, 1998).
Since transcriptional activators have been shown to compete
for low abundant coactivators (Kamei et al., 1996; Fryer and
Archer, 1998), it is likely that expressing the multipotent
VP16 activation domain can easily interfere with subtle
equillibria of protein±protein interaction (Berger et al.,
1990). Selecting for gene trap events that give rise to
TetR-VP16 expression in ES cells and in a widespread
manner during embryogenesis might, therefore, have intro-
duced a bias for low abundant expression of the activator.
If increasing concentrations of TetR-VP16 can compen-
sate for a chromatin-mediated repression of activator func-
tion, appropriate changes in chromatin structure might
compensate for low activator concentrations. Several
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Fig. 7. MEFs were incubated with and without tetracycline at different concentrations of butyrate and TSA, respectively. (A) TOP96 £ M34-MEFs treated with
butyrate. (B) TOP96 £ M34-MEFs treated with TSA. (C) TOP97 £ M34-MEFs treated with TSA. Where indicated, cells were incubated with tetracycline for 2
days, before butyrate or TSA was added for 24 h. Subsequently cells were harvested and extracts were analyzed for alkaline phosphatase (AP) activity.
Columns represent mean values of three independent experiments done in parallel. Bars represent standard deviations. AP activities are given on a relative
scale. Values measured for cells, cultured in the presence of tetracycline but in the absence of histone deacetylase inhibitor, were set to 1. (D) TOP97 £ M34-
MEFs were treated with different concentrations of TSA as described above. Afterwards RNA was isolated and equal amounts were subjected to Northern
blotting. The blot was co-hybridized with tTA and hAP probes. The hAP probe detects two different transcripts resulting from alternative splicing of the SV40
sequences (see Fig. 1).
studies have indicated that histone hyperacetylation can
alleviate the repressive in¯uence of chromatin proteins on
transcription factor binding to DNA (Lee et al., 1993;
Vettese-Dadey et al., 1996). Inhibition of histone deacety-
lases (HDACs) induces global hyperacetylation of histones
(Candido et al., 1978; Sealy and Chalkley, 1978). This has
been shown for many vertebrate cell types, including mouse
®broblasts (Candido et al., 1978). Incubating primary
embryonic ®broblasts in the presence of HDAC inhibitors
we observed a dramatic stimulation of target gene activity
when and only when the activator was allowed to bind its
operator site (Fig. 7). This suggests that TetR-VP16 is sensi-
tive to changes in the acetylation state of chromatin. Alter-
natively it might be assumed that inhibition of HDACs gives
rise to hyperacetylation of TetR-VP16 potentiating its func-
tion. Eukaryotic transcription factors have recently been
found to be substrates of histone acetyltransferases and acet-
ylation was shown to either positively or negatively affect
their DNA binding af®nity (Gu and Roeder, 1997; Munshi et
al., 1998). However, it appears to be highly unlikely that the
prokaryotic Tet repressor could accidentally be regulated
this way in eukaryotic cells.
It has recently been demonstrated that sequences in the
chicken b-globin locus control region protect a globin gene
from inactivation by maintaining relative hyperacetylation
of its chromatin in erythroid cells (Pikaart et al., 1998).
Identi®cation of cis-acting elements bestowing a suf®cient
degree of histone acetylation on juxtaposed chromatin in a
broad range of cell types might help to establish tetracy-
cline-dependent transgenes in mouse embryos.
In summary we conclude that concentration, as well as,
the state of chromatin acetylation are likely to be important
determinants for TetR-VP16 function. Hyperacetylation of
histones can compensate for ineffective target gene activa-
tion at lower concentrations of TetR-VP16, whereas higher
concentrations largely dispense the activator from in¯u-
ences of the acetylation state of chromatin. This perfectly
agrees with observations in yeast showing that overexpres-
sion of transcriptional activators can overcome activational
defects resulting from loss of function mutations in the
histone acetyltransferase Gcn5 (Georgakopoulos and Thir-
eos, 1992; Greogory et al., 1998).
3.2. Promoter preactivation and histone hyperacetylation
The tTA-dependent epidermal expression in TOP47 £
M34 embryos relies on a speci®c regulatory quality of the
target gene's integration site. The endogenous cis-acting
elements which must account for this position effect do
not directly activate the target gene but obviously synergize
with tTA-loci in target gene activation. Hence, they are
functionally different from those enhancer elements which
activate the target gene in a tTA-independent manner, e.g. in
the cartilage anlagen of the limbs. For this reason they are
appropriately described as elements preactivating the tetO-
promoter with respect to TetR-VPl6 function. Preactivation
most likely involves modi®ed chromatin structures which
facilitate the access of activator to DNA but, nevertheless,
do not cause derepression of the core promoter. We demon-
strate that histone hyperacetylation is a possible mechanism
for promoter preactivation. For numerous transcriptional
activators including nuclear receptors (Chakravati et al.,
1996; Kamei et al., 1996; Kraus and Kadonaga, 1997;
Blanco et al., 1998), MyoD (Yuan et al., 1996), NF-kB
(Zhong et al., 1998) and cubitus interruptus (Akimura et
al., 1997) there is strong experimental evidence that the
interaction with histone acetyltransferases is a critical part
of their activational function. The observation that histone
hyperacetylation preactivates the tetO-promoter suggest
that at least at the CMV core promoter other activator func-
tions in addition to those recruiting histone acetyltransferase
activity are necessary for ef®cient transcriptional activation.
Uncoupling the necessary remodeling of promoter chroma-
tin from the activation process proper, principally allows to
encode expression patterns at the level chromatin structure.
The modi®cation of chromatin structure might therefore be
one major goal of ontogenetic determination processes.
4. Experimental procedures
4.1. Vector constructions
Plasmid pGT1.8 (kindly provided by W.C. Scarnes) was
completely digested with HindIII followed by partial diges-
tion with XbaI. Resulting plasmid pieces were blunted using
the Klenow fragment. A 5.8 kb DNA fragment carrying
mouse En2 derived sequences fused to b -geo was cloned
into the blunted XbaI site of IRES-tTA (kindly provided by
Luc St-Onge) yielding vector pM26.22. Correct orientation
of the insert was checked by digesting the vector with XbaI.
To construct pM4l.1 a 696 bp BamHI/MscI fragment was
deleted from pUHG15-1 (Gossen and Bujard, 1992). The
deleted fragment comprises the rabbit b -globin intron. After
blunting the vector was religated to yield pM11.1. Finally a
3.45 kb NruI/ScaI fragment of pM26.22 was exchanged for
a 2.76 kb NruI/ScaI fragment of pM11.1 to yield gene trap
vector pM4l.1.
To produce pM42.7 a 474 bp XhoI/XbaI fragment from
pUHG10-3 (Gossen and Bujard, 1992) was inserted into the
singular HindIII site of phAP-SV (kindly provided by C.
Neville and N. Rosenthal) using T4 ligase after blunting
of vector and insert ends. The insert comprises the tetO
promoter. Correct insert orientation with respect to the
hAP open reading frame was examined by HindIII digest.
4.2. Cell culture
R1 embryonic stem cells (Nagy et al., 1993) have been
kept and handled basically as described (Torres and
Mansouri, 1994). Vector DNA was prepared using Qiagen
columns. Prior to electroporation, vector DNA was linear-
ized by digest with AseI (pM26.22) and ScaI (pM41.1),
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respectively. Neomycin resistant and b -galactosidase posi-
tive clones were aggregated with morulae as described
(Nagy et al., 1993). Primary embryonic ®broblast (MEFs)
were basically prepared as described (Torres and Mansouri,
1994). MEFs were prepared from all embryos of one litter.
To assure that MEFs of the desired genotype were included
in the preparation, biopsies were taken from embryos for
genotyping. MEFs were cultured at 378C and 5% CO2 in
DMEM (1 g Glucose/l, Gibco-BRL) containing 100 U Peni-
cillin/ml, 100 mg Streptomycin/ml, 10% heat inactivated
FCS (Gibco-BRL), 2 mM L-Glutamin (Gibco-BRL).
MEFs were transfected using the calcium±phosphate tech-
nique. In brief, DNA which included 1 mg of RSV-CAT
(kindly provided by G. Chalepakis), different amounts of
pUHG15-1 (Gossen and Bujard, 1992) and pBluescript
(Stratagene) add 5 mg of total DNA was dissolved in 125
ml H2O and mixed with 125 ml 0.5 M CaCl2. Finally the
mixture was dripped into 2 £ HeBS buffer (50 mM HEPES,
1.5 mM Na2HPO4, 280 mM NaCl, pH 7.05) for a period of
about 6 s while the buffer was gently vortexed. After an
incubation of 20 min at room temperature the precipitates
were dripped onto the cells which were grown on 9 cm
plates. Two hours before and 20 h after transfection medium
was changed. Cells were harvested at 37 h after transfection
for preparation of extracts.
Stock solutions of histone deacetylase inhibitors were
prepared by dissolving butyrate (Sigma) in water and TSA
(Sigma) in DMSO at a thousand-fold higher concentration
than used in cell culture. Solutions were stored at 2208C. To
cells treated with `0 nM TSA' 10 ml of DMSO/10 ml of
culture medium were added. Tetracycline (Boehringer) was
dissolved in ethanol at a concentration of 5 mg/ml and
stored at 2208C. Cells were treated with TSA and butyrate
for 24 h. Those cells which were additionally treated with
tetracycline were incubated in tetracycline containing
medium for 48 h in advance.
4.3. Microinjection and mice strains
To produce founder TOP founder animals a 3 kb NotI/
SalI fragment from pM42.7 was microinjected into zygotes
of FVB mice at a concentration of 2 ng/ml as described
(Hogan et al., 1994). To isolate the 3 kb fragment from
pM42.7 the vector was digested with NotI, SalI and Scal.
The fragment was isolated from agarose gel after electro-
phoresis using Qiaex II (Qiagen).
Transgenic animals were bred to NMRI mice to build up
and maintain colonies.
4.4. Northern blot analysis
Total RNA was isolated as described (Hogan et al., 1994).
However, tissue homogenates were additionally sonicated
after preparation. After phenol/chloroform extraction RNA
was precipitated using NaCl. Precipitates were ®nally
dissolved in DEPC treated H2O and stored at 2708C.
Total RNA (25 mg) was separated by electrophoresis at
0.9 V/cm in MOPS buffer (20 mM MOPS pH 7.0, 1 mM
EDTA, 8 mM sodium acetate) through 1% agarose gels
containing 2.2 M formaldehyde. RNA was transferred to
Nylon membranes (Qiagen) in 20 £ SSC by capillary ¯ow
and ®xed by UV irradiation (0.3 J/cm2, at 312 nm).
Membranes were hybridized with P32-labelled random
primed DNA probes in hybridization buffer (0.5 M sodium
phosphate pH 7.2, 7% SDS) at 688C. The DNA template
used for tTA probe preparation was a 1 kb BamHI fragment
comprising the whole tTA open reading frame isolated from
plasmid pM44.2 (unpublished data). The template used for
hAP probe preparation was a 1.7 kb XbaI fragment isolated
from plasmid pM42.7 (Fig. 1C).
4.5. Immunoblotting
About 5 £ 106 MEFs were sonicated in 100 ml of HEPES
buffer (20 mM HEPES pH 7.5, 150 mM NaCl, 25%
glycerol, 0.2 mM EDTA, 1 mM phenylmethylsulfonyl
¯uoride). Embryos were homogenized in HEPES buffer
prior to soni®cation.
Proteins were electrophoresed in a dicontinuous SDS-
PAGE with a 5% stacking and 12% separating gel. Subse-
quently proteins were blotted to PVDF membranes (Milli-
pore) in transfer buffer (39 mM Glycine, 48 mM Tris±Base,
0.03% SDS, 10% Methanol) at 1 mA/cm2 for 1 h 30 min
using a LKB 2117 Multiphor II electrophoresis cell. Anti-
body incubations were done in PBS (137 mM NaCl, 2.7 mM
KCl, 8.1 mM sodium phosphate, potassium phosphate, pH
7.4) with 5% milk powder and 1% Tween 20. TetR-VP16
was detected using a rabbit anti-TetR antiserum (kindly
provided by W. Hillen) at a dilution of 1:2500 and horse-
radish peroxidase conjugated goat anti-rabbit antiserum at a
dilution of 1:5000 (Cappel). Bound secondary antibody was
visualized using the enhanced luminescence kit (Amer-
sham).
4.6. Measurement of enzymatic activities
After culture on six well plates, ®broblasts were rinsed
(3£) with PBS on the culture plate, scraped from the wells in
1 ml PBS, brie¯y spun down and ®nally lysed in 200 ml of
ethanolamine buffer (10 mM ethanolamine pH9.5, 0.5 mM
MgCl2, 4% Chaps)/well. After a brief soni®cation in 1.5 ml
caps the cell lysate was incubated for 30 min at 658C, centri-
fuged at 25 000 £ g and 48C for 5 min. Fifty microliters of
the supernatant were mixed with 150 ml 1 £ Phospha dilu-
tion buffer (Tropix) and incubated for 1 h at 658C. From this
100 ml were mixed with 100 ml of Phospha assay buffer
(Tropix) and incubated for 5 min at room temperature.
Finally 100 ml of Phospha reaction buffer (Tropix) were
added. RLUs were measured using a Lumat LB 9501 (Bert-
hold). Values measured at the point of maximal light emis-
sion were normalized according to protein concentration.
Relative protein concentrations were determined after Brad-
ford (Bradford, 1976).
Chloramphenicol acetyltransferase (CAT) activities were
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measured as described elsewhere (Sambrook et al., 1989).
Results of CAT assays were quantitated using an instant
imager (Packard).
4.7. X-phosphate staining of embryos
Embryos were prepared from their deciduae in ample
PBS/MgCl2 (2mM) and visceral yolk sac epithelia isolated
for subsequent DNA extraction. Embryos were ®xed in 4%
Paraformaldehyde (PFA)/PBS/MgCl2 (2 mM) over night.
The next day embryos were rinsed 3 £ in PBS/MgCl2 (2
mM) for 20 min each and afterwards incubated for 1 h at
658C. Subsequently embryos were incubated in freshly
prepared hAP buffer (100 mM Tris pH 9.5, 100 mM
NaCl, 50 mM MgCl2, 0.1% Tween-20, 2 mM Levamisol)
for 30 min at room temperature and ®nally stained in freshly
prepared staining solution (100 mM Tris pH 9.5, 100 mM
NaCl, 50 mM MgCl2, 0.1% Tween-20, 2 mM Levamisol,
0.1 mg/ml 5-bromo-4-chloro-3-indolylphosphate (X-phos-
phate), 1 mg /ml nitroblue tetrazolium chloride (NBT)) on
ice over night. After staining embryos were carefully rinsed
in PBS/EDTA (20 mM) and once again ®xed in 4% PFA/
EDTA (20 mM).
X-phosphate and NBT stock solutions were prepared at a
concentration of 10 mg/ml of water and 50 mg/ml of 70%
dimethylformamide and stored at 2208C.
4.8. X-Gal staining of embryos
Embryos ®xed for lh on ice with 1% formaldeyde/0.2%
glutaraldehyde in PBS, containing 2 mM MgCl2. After
rinsing 3 £ with PBS, staining was performed in PBS
containing 0.1% X-Gal, 2 mM MgCl2, 5 mM
K3[Fe(CN)6], 5 mM K4[Fe(CN)6] in the dark at 308C over-
night.
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